Autopsy report · NCT01238653

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

“Slow enrollment with limited population for study parameters.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Pathfinder Therapeutics

Sponsor type

Industry

Conditions

Liver Cancer

Participants

8

Sites

1

Countries

United States

Trials that died the same way

• Study in Adult Subjects Undergoing Posterolateral Thoracotomy
  “Slow study enrollment” (84% match in meaning)
• Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
  “Slow enrollment of eligible subjects” (82% match in meaning)
• T2 FSL2 Weight Loss
  “Slow enrollment and Study no longer required” (81% match in meaning)
• Confocal Endomicroscopy for Biliary Strictures -Phase I
  “Difficult (slow) Enrollment” (81% match in meaning)
• Photon/Proton Radiation Therapy for Oropharyngeal Cancers
  “Slow enrollment, feasibility issues” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.